Showing results (41-50 of 180) with videos related to
Sort By:
Pageof 18
Therapeutic Advances in Neurological Disorders|January 21, 2016
Evidence for the efficacy and effectiveness of THC-CBD oromucosal spray in symptom management of patients with spasticity due to multiple sclerosisUwe K Zettl, Paulus Rommer, Petra Hipp, et al.Der Nervenarzt|July 23, 2020
[Headache in multiple sclerosis]Marcel Gebhardt, Peter Kropp, Frank Hoffmann, et al.Journal of Neurology|August 27, 2010
Sonographic basal ganglia alterations are related to non-motor symptoms in multiple sclerosisSebastian Horowski, Uwe K Zettl, Reiner Benecke, et al.Scientific Reports|September 2, 2023
Side effects following vaccination in multiple sclerosis: a prospective, multi-centre cohort studyAlexander Winkelmann, Christoph Metze, Uwe K Zettl, et al.European Neurology|October 29, 2018
Headache at the Time of First Symptom Manifestation of Multiple Sclerosis: A Prospective, Longitudinal StudyMarcel Gebhardt, Peter Kropp, Frank Hoffmann, et al.Frontiers in Immunology|April 30, 2019
The Cerebrospinal Fluid in Multiple SclerosisFlorian Deisenhammer, Henrik Zetterberg, Brit Fitzner, et al.CNS Neuroscience & Therapeutics|April 11, 2018
Coping behavior in multiple sclerosis-complementary and alternative medicine: A cross-sectional studyPaulus S Rommer, Nicolaus König, Annett Sühnel, et al.Current Pharmaceutical Design|May 23, 2012
An inventory of short term and long term changes in gene expression under interferon β treatment of relapsing remitting MS patientsBrigitte K Paap, Alexander Hundeshagen, Michael Hecker, et al.Current Pharmaceutical Design|November 1, 2006
Comparative genomics for the investigation of autoimmune diseasesSteffen Möller, Uwe K Zettl, Pablo Serrano-Fernández, et al.Journal of Muscle Research and Cell Motility|September 14, 2004
Long-term growth selection of mice changes the intrinsic susceptibility of myogenic cells to apoptosisCharlotte Rehfeldt, Ulla Renne, Matthias Wittstock, et al.Pageof 18